Your session is about to expire
← Back to Search
Chemotherapy and Stem Cell Transplant for Germ Cell Cancer
Study Summary
This trial is studying how well standard-dose combination chemotherapy works compared to high-dose combination chemotherapy and stem cell transplant in treating patients with germ cell tumors that have returned after a period of improvement or did not respond to treatment.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My germ cell tumor has grown or returned after one round of chemotherapy.My cancer has been confirmed as GCT by a pathologist.I've had 3-6 rounds of initial chemo with cisplatin. Up to 7 if I needed urgent treatment.
- Group 1: Arm A: TIP
- Group 2: Arm B: TI-CE
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other scientific studies have been done using this same treatment?
"City of Hope Comprehensive Cancer Center first ran this trial in 1997 and there have been 2906 completed studies since. Currently, 1860 more trials are being conducted with many of them taking place in Commack, New jersey."
What are some of the most well-known conditions that this medication helps to improve?
"This course of action is frequently used to treat lymphoma and non-Hodgkin. In addition, it can be used to manage other disorders like locally advanced non-small cell lung cancer, and initial cancer treatment."
Does this medication have the government's seal of approval?
"The safety of this treatment falls on the third tier of our 1-3 scale because this is a Phase 3 trial. This indicates that not only is there some data supporting the efficacy of the treatment, but there are multiple rounds of data that support its safety."
Are participants currently being enrolled in this research?
"Indeed, the clinicaltrials.gov website indicates that this study is still recruiting patients. The first posting was on March 1st, 2015, with the most recent update on September 25th, 2022. There are 63 different recruitment sites for this trial, and the goal is to enroll 420 patients in total."
Share this study with friends
Copy Link
Messenger